KalVista Pharmaceuticals, Inc.
Board Member
2024-04-18–present
Board Member
KalVista Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
William Fairey is recorded as Board Member at KalVista Pharmaceuticals, Inc.. KalVista Pharmaceuticals, Inc. reported in an 8-K filed June 11, 2026 that William Fairey resigned as member of the Company's board of directors. KalVista Pharmaceuticals, Inc. reported in an 8-K filed April 22, 2024 that William Fairey was appointed Class III Director, effective April 18, 2024.
“each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof”
“On April 18, 2024 upon the recommendation of the Nominating and Governance Committee of the Board, the Board approved the appointment of William Fairey (“Mr. Fairey”) to the Board effective immediately, to serve until his successor is duly elected and qualified, or until his death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
KalVista Pharmaceuticals, Inc.
Board Member
SEC 8-K
2024-04-18–present
KalVista Pharmaceuticals, Inc.
Board Member
Proxy statement
Start not stated–2026-06-11
Recorded roles and call appearances connecting this person to public companies.
KalVista Pharmaceuticals, Inc.
Board Member
2024-04-18–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
KalVista Pharmaceuticals, Inc.